Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
May 1, 2017 DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
April 30, 2018 DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
April 26, 2019 DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
April 23, 2020 DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
April 22, 2021 DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
April 28, 2022 DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
March 1, 2023 DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
April 28, 2023 DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
April 25, 2024 DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 10, 2023 NT 10-Q

Notification that form type 10-Q will be submitted late

View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us